NCT02630628View on ClinicalTrials.gov

Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

December 5, 2015

Primary Completion Date

December 27, 2024

Study Completion Date

December 27, 2024

Conditions
Lupus Nephritis
Interventions
DRUG

Tacrolimus

Dosage: start at 2mg twice a day, then titrated according to therapeutic drug level monitoring using 12-hour post-dose blood sampling

DRUG

Mycophenolate mofetil

Dosage: start at 1g twice a day, then taper as per protocol

Trial Locations (1)

Unknown

The University of Hong Kong, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT02630628 - Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis | Biotech Hunter | Biotech Hunter